Related Experiment Video
Updated: Jan 30, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Poly I:C-based rHBVvac therapeutic vaccine eliminates HBV via generation of HBV-specific CD8+ effector memory T cells
Hua-Jun Zhao1, Qiu-Ju Han1, Guan Wang1
1Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, Jinan, China.
Insights
A new therapeutic vaccine (pHBV-vaccine) effectively reduced hepatitis B virus (HBV) DNA and antigens in mice. This vaccine restores T cell function and may offer a potential cure for chronic hepatitis B (CHB).
Area of Science:
- Immunology
- Virology
- Vaccinology
Background:
- Chronic hepatitis B (CHB) is a significant global health issue with limited curative treatments.
- Developing effective therapeutic vaccines remains a critical challenge in managing CHB.
Purpose of the Study:
- To evaluate the feasibility and efficacy of a poly I:C-adjuvanted therapeutic HBV vaccine (pHBV-vaccine) in a mouse model of CHB.
- To investigate the immunological mechanisms underlying the vaccine's therapeutic effects.
Main Methods:
- HBV-carrier mice were treated with the pHBV-vaccine.
- Assessed viral markers (HBsAg, HBV DNA), dendritic cell maturation, T cell responses (CD8+ T cell exhaustion, proliferation, polyfunctionality), and cytokine profiles (IL-12).
Main Results:
- The pHBV-vaccine significantly reduced HBsAg and HBV DNA levels safely.
- It promoted dendritic cell maturation and antigen presentation, restored exhausted CD8+ T cells, and broke immune tolerance.
- The vaccine enhanced HBV-specific T cell proliferation and polyfunctionality, inducing effector memory short-lived effector cells (SLECs) crucial for viral clearance.
Conclusions:
- The pHBV-vaccine demonstrates significant therapeutic potential for CHB by restoring anti-HBV immunity.
- This study provides a foundation for developing pHBV-vaccine as a clinical candidate for CHB therapy.
Objective:
Chronic hepatitis B (CHB) virus infection is a global health problem. Finding a cure for CHB remains a challenging task.
Design:
In this study, poly I:C was employed as an adjuvant for HBV therapeutic vaccine (referred to as pHBV-vaccine) and the feasibility and efficiency of pHBV-vaccine in CHB treatment were evaluated in HBV-carrier mice.
Results:
We found that pHBV-vaccine decreased HBsAg and HBV DNA efficiently and safely in HBV-carrier mice. Further investigation showed that pHBV-vaccine promoted maturation and antigen presentation ability of dendritic cells in vivo and in vitro. This vaccine successfully restored the exhaustion of antigen-specific CD8+ T cells and partly broke the immune tolerance established in HBV-carrier mice. pHBV-vaccine also enhanced the proliferation and polyfunctionality of HBV-specific CD11ahi CD8αlo cells. Importantly, we observed that T cell activation molecule KLRG1 was only expressed on HBV specific CD11ahi CD8αlo cells. Furthermore, pHBV-vaccine reduced the expression of Eomes and increased the serum IL-12 levels, which in turn promoted the generation of effector memory short-lived effector cells (SLECs) to exhibit a critical role in HBV clearance. SLECs induced by pHBV-vaccine might play a crucial role in protecting from HBV reinfection.
Conclusions:
Findings from this study provide a new basis for the development of therapeutic pHBV-vaccine, which might be a potential candidate for clinical CHB therapy.
More Related Videos
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
09:17A DNA/Ki67-Based Flow Cytometry Assay for Cell Cycle Analysis of Antigen-Specific CD8 T Cells in Vaccinated Mice
Published on: January 5, 2021
Related Concept Videos
Vaccinations
Cardiovascular Drugs: Classification based on Therapeutic Indications
Cell Specific Gene Expression
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
System of Memory
Working Memory